CSNRDARRC Pep-LNP
Cat. No.: TDLD-0126-LD77
CSNRDARRC Pep-LNP
CSNRDARRC Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP), engineered for targeted delivery of therapeutic cargoes. The CSNRDARRC peptide enables specific receptor binding, enhancing stability and reducing non-specific interactions for precise delivery applications. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear All
For Research Use Only. Not for Diagnostic or Treatment Applications.
| Payload Type | mRNA |
| Payload | Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others |
| Capping | Cap 1 |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Peptide |
| Targeting Module | CSNRDARRC Peptide |
| Lipid Formulation | DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other |
| Dye | Unlabeled; DiR; DiD; DiO; DiI; Other |
| Application | Control; Targeted Delivery; Gene Therapy |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Related Products
TMTP1 Pep-LNP (TDLD-0126-LD145)
KLVFF Pep-LNP (TDLD-0126-LD158)
CD37 CAR mRNA-LNP (TDLD-0825-LD52)
Targeted CD8 Ab-LNP (TDLD-0126-LD57)
ASP6 Pep-LNP (TDLD-0825-LD88)
CKAAKN Pep-LNP (TDLD-0126-LD69)
PCM Pep-LNP (TDLD-0825-LD93)
HP2 Pep-LNP (TDLD-0126-LD103)
Online Inquiry
